• Ep 236 "Perspectives on Treatment Developments for Psoriatic Disease"

  • Oct 8 2024
  • Length: 26 mins
  • Podcast

Ep 236 "Perspectives on Treatment Developments for Psoriatic Disease"

  • Summary

  • Over 20 years ago biologics were introduced for psoriasis and PsA. Since then even more targeted treatments have been introduced. Listen as dermatologist Dr. Steven Feldman from Wake Forest University School of Medicine, shares his perspectives on the latest treatments, resident memory T-cells, and what's to come (such as an oral IL-23 agent) with moderator Max Blitstein. This episode is provided with support from Bristol Myers Squibb.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Ep 236 "Perspectives on Treatment Developments for Psoriatic Disease"

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.